Harrison & Co Wealth Management’s Medifast MED Stock Holding History

Harrison & Co Wealth Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$685K	Buy	+5,938	New	+$691K	0.66%	64

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Harrison & Co Wealth Management's MED Position: Q4 2022 in Review

Harrison & Co Wealth Management opened a new position in Medifast (MED) in Q4 2022: 5,938 shares worth $685K. The stake represents 0.66% of the portfolio and ranks #64 among its holdings.

277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

Harrison & Co Wealth Management held 5,938 shares of Medifast worth $685K as of Q4 2022.
Medifast was a new Harrison & Co Wealth Management position in Q4 2022.
Medifast made up 0.66% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #64 holding.
277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.